KTTAW
Income statement / Annual
Last year (2024), Pasithea Therapeutics Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Pasithea Therapeutics Corp.'s net income was -$13.90 M.
See Pasithea Therapeutics Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$15.06 K |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$5.09 K
|
$17.28 K
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
-$5.09 K
|
-$2.21 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
-0.15
|
0
|
| Research and Development Expenses |
$7.20 M
|
$8.10 M
|
$2.67 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$7.05 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.05 M
|
$0.00
|
$9.92 M
|
$0.00
|
$0.00
|
| Other Expenses |
$0.00
|
$7.88 M
|
$0.00
|
$4.51 M
|
$61.48 K
|
| Operating Expenses |
$14.25 M
|
$15.98 M
|
$12.58 M
|
$4.51 M
|
$61.48 K
|
| Cost And Expenses |
$14.25 M
|
$15.98 M
|
$12.59 M
|
$4.52 M
|
$61.48 K
|
| Interest Income |
$423.18 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$102.00
|
$508.00
|
$0.00
|
| Depreciation & Amortization |
$649.03 K
|
$648.45 K
|
$5.09 K
|
$1.38 K
|
$61.48 K
|
| EBITDA |
-$13.60 M |
-$15.33 M |
-$11.72 M |
-$4.51 M |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
-299.17
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
-299.26
|
0
|
| Total Other Income/Expenses Net |
$345.38 K
|
$471.61 K
|
$861.09 K
|
$2.33 M
|
$0.00
|
| Income Before Tax |
-$13.90 M
|
-$15.51 M
|
-$11.73 M
|
-$2.17 M
|
-$61.48 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
-144.3
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$13.90 M
|
-$15.96 M
|
-$13.94 M
|
-$2.17 M
|
-$61.48 K
|
| Net Income Ratio |
0
|
0
|
0
|
-144.3
|
0
|
| EPS |
-12.69 |
-12.65 |
-10.34 |
-1.89 |
-0.0594 |
| EPS Diluted |
-12.69 |
-13.01 |
-10.34 |
-1.89 |
-0.0594 |
| Weighted Average Shares Out |
$1.10 M
|
$1.26 M
|
$1.26 M
|
$1.15 M
|
$688.92 K
|
| Weighted Average Shares Out Diluted |
$1.10 M
|
$1.23 M
|
$1.26 M
|
$1.15 M
|
$688.92 K
|
| Link |
|
|
|
|
|
